文献速递胸部肿瘤

滋养层糖蛋白与间皮瘤良好预后相关并可作为抗体药物偶联物靶点

Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug Conjugates.
PubMed 文献 · J Thorac Oncol · 2018-06-27

研究评估滋养层糖蛋白(5T4)在间皮瘤中的表达及其作为抗体药物偶联物(ADC)靶点的可行性。5T4在12株(原代)间皮瘤细胞系中10株表达,高表达与较长无进展生存相关;两种5T4靶向ADC可杀伤高表达细胞系。

要点

  • 5T4在多数间皮瘤细胞系和活检标本中表达,高表达与较长无进展生存相关。
  • 5T4靶向抗体和ADC可内化进入溶酶体。
  • 三种5T4靶向ADC中两种对高表达5T4的间皮瘤细胞系有细胞毒性。

核心结论

  • 5T4抗原在间皮瘤中表达,基于5T4的ADC可内化进入溶酶体并杀伤间皮瘤细胞,有望成为间皮瘤的选择性治疗策略。

研究设计与样本

  • 在(原代)间皮瘤细胞系和活检标本中评估5T4抗原表达,并与临床结局进行相关性分析。
  • 在表达5T4的细胞中评估内化,并在(原代)间皮瘤细胞上测试三种5T4靶向ADC的细胞毒性。

主要发现

  • 5T4在12株(原代)间皮瘤细胞系中10株表达。
  • 大多数活检标本5T4抗原染色阳性,染色强度和阳性细胞百分比存在显著差异。
  • 5T4高表达与较长无进展生存相关。
  • 针对5T4的游离抗体和ADC均被内化并进入溶酶体腔室。
  • 细胞毒性实验显示,5T4高表达的细胞系对三种ADC中的两种敏感。

关键数值与推荐

  • 5T4在12株(原代)间皮瘤细胞系中10株表达。
  • 三种5T4靶向ADC中,两种对5T4高表达细胞系有细胞毒性。
  • 第三种ADC缺乏疗效的情况可通过氯喹中和溶酶体腔室而恢复。

临床怎么用

  • 5T4可作为间皮瘤ADC靶向治疗的选择性策略,高表达可能提示预后较好。

局限性

  • 研究主要基于细胞系和活检标本的体外实验,尚未提供临床疗效数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The prognosis for patients with mesothelioma is poor, which prompts the need for the development of better treatment options. Antibody drug conjugates (ADCs) are gaining interest as a therapeutic strategy in mesothelioma. Trophoblast glycoprotein (5T4) is an oncofetal protein overexpressed in mesothelioma with low expression in normal tissue and therefore a good candidate for ADC treatment. Here, we evaluated and manipulated 5T4 as a suitable antigen for ADC targeted therapy in patients with mesothelioma. METHODS: Expression of the 5T4 antigen is evaluated in (primary) mesothelioma cell lines and biopsy specimens, and correlated with clinical outcome. Internalization was assessed in 5T4 expressing cells. The cytotoxicity of three different 5T4-targeting ADCs was tested on (primary) mesothelioma cells. RESULTS: 5T4 was expressed in 10 of 12 (primary) cell lines. Most biopsy specimens stained positive for the 5T4 antigen, with marked differences in staining intensity and percentage of positive cells. High expression correlated with long progression-free survival. Both free antibody and ADCs targeting 5T4 were internalized and entered lysosomal compartments. Cytotoxicity experiments showed that cell lines with a high expression for 5T4 were sensitive to two of three ADCs. Lack of efficacy for the third ADC could be restored by neutralizing lysosomal compartments with chloroquine. CONCLUSIONS: The 5T4 antigen is expressed in mesothelioma and 5T4-based ADCs are internalized in lysosomes. Two of three ADCs were capable of killing the mesothelioma cells; the third ADC required additional lysosomal neutralization for its effect. 5T4-based ADCs would be a selective strategy for the treatment of mesothelioma.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Schunselaar LM, Monkhorst K, van der Noort V, et al. Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug Conjugates. J Thorac Oncol. 2018. PMID: 29959059. doi:10.1016/j.jtho.2018.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。